ANIK — Anika Therapeutics Share News
0.000.00%
Last trade - 00:00- $286.66m
- $248.25m
- $112.82m
Irenic Capital urges Theravance to conduct review, add shareholder to board
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-VerifyMe, Molson Coors, Sigma Lithium
Anika Therapeutics rises as shareholder asks drugmaker to sell itself
-Caligan urges Anika Therapeutics to conduct review, plans board challenge (updated)
Brief: Caligan Partners Issues Open Letter To Anika Board
Caligan urges Anika Therapeutics to conduct strategic review, plans board challenge
U.S. RESEARCH ROUNDUP-Amyris, HanesBrands, Roblox
Brief: Anika Therapeutics Inc Reports Quarterly Loss Per Share Of $0.29
Advisory: Stock alerts on Anika Therapeutics and Sasol withdrawn
Anika Therapeutics up as pain relief drug meets main goal in late-stage study
Brief: Anika’S Cingal Successfully Achieves Primary Endpoint In Third Phase Study
Brief: Anika Therapeutics Inc - Limited Market Release And First Surgeries Performed Using X-Twist Fixation System
Brief: Anika Therapeutics Q2 Adjusted Loss Per Share $0.12
Brief: Anika Receives FDA 510(K) Clearance For The X-Twist Knotless Fixation System
U.S. RESEARCH ROUNDUP- Black Knight, Dish Network, Whirlpool
Brief: Anika Therapeutics Q1 Loss Per Share $0.20
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Brief: Anika Reports Q4 Adjusted Loss Per Share $0.23